Carbacid Chairman Dennis Awori last week argued that the offer was fair and represents a “realistic underlying value of BOC Kenya. [Courtesy]Like a cornered hunter, BOC Kenya is refusing to go down easily ahead of an impending Sh1.2 billion buyout by Carbacid. “As the fair value is below the offer price, the offer price is not considered to be fair and reasonable,” said Dyer and Blair. “The offer price relies on this valuation method, which is widely accepted as the most authoritative valuation method of the business as a going concern. It noted that the Covid-19 pandemic had peaked demand for oxygen – BOC Kenya’s core business - and provided an opportunity for growth.

Source: Standard Digital March 01, 2021 18:21 UTC